PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|7|991-1002

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.7, 2015-06, pp. : 991-1002

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 369-375

Karger

Access to resources Recommend Favorite

Complete clinical response to neoadjuvant chemoradiotherapy for rectal cancer: an Australasian perspective

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 3, 2015-03 ,pp. : 103-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of the inferior mesenteric vein diameter as a surrogate marker to evaluate response to neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

By  

COLORECTAL DISEASE, Vol. 20, Iss. 1, 2018-01 ,pp. : 75-76

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence‐free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4231-4241

John Wiley & Sons Inc

Access to resources Recommend Favorite

High infiltration of tumor‐associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 6, 2015-05 ,pp. : 752-759

John Wiley & Sons Inc

Access to resources Recommend Favorite